New stock pick: Intellicheck, Inc. (IDN stock) analysis, valuation, earnings forecasts.

Updated: Nov 17, 2020

I added Intellicheck, Inc. (IDN stock) to my portfolio.

Intellicheck, Inc. engages in the development, integration, and marketing of threat and identity authentication solutions. It offers professional services, retail, age, defense, guest, and port ID. The company was founded in 1994 and is headquartered in Melville, NY.

The key reasons for adding Intellicheck, Inc. (IDN stock) to my portfolio are:

  1. the recent quickly accelerated revenue growth which converts to earnings.

  2. Intellicheck, Inc. is about to show profit and has already shown a profit in the latest 2 quarters.


With an expected EPS of $0.325 for IDN stock at the end of 2021 and the current price of $7.91, the forward Price-to-Earnings ratio is 24. This is still a bit high. However, I would like to note how Intellicheck, Inc. (IDN stock) has been constantly beating EPS predictions for the past 3 quarters. If it reaches an EPS of $0.45, the PE ratio for IDN stock will be 17.6.

The question here is: will Intellicheck, Inc. (IDN stock) grow at the same rate past the end of 2021?

The company seems to be doing great in terms of revenue growth. Based on Intellicheck, Inc. investor presentation the company has been adding quite a few large clients. To read the list of new clients check this document starting page 13

On top of the list of clients in investors' presentation, the company announced the addition of another Midwest-based financial institution with nearly 1,200 branches in 26 states with an associated business presence in 39 states.

This leads me to hopes that Intellicheck, Inc. (IDN stock) will beat earnings estimates for the upcoming release of Q2 results (on August 11th).

For a company with a market cap of $140 million, there is quite some interest to the company from institutions. This also means the public float is very small.


1,611,411 of those shares institutions currently hold were added very recently:


Lastly, based on there are 3 analysts covering IDN stock. 2 of them give the stock a BUY rating, 1 - HOLD. The average target price for the stock is $11 (to remind, the current price is $7.91)


Recent Posts

See All

ATNX: way oversold, doubling down here

Doubled down on ATNX at $5.32. The company is down 50% today based on quarterly results and FDA rejection of their drug. However: 1. the company still has room to fight the decision 2. the company has

  • Pinterest
  • Instagram
  • Facebook